Synthetic glycol-split heparin tri- and tetrasaccharides provide new insights into structural peculiarities for antiheparanase activity
Bioorganic & Medicinal Chemistry · 2025
DOI: 10.1016/j.bmc.2024.118052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2025. Verfasst von Minghong Ni und 12 weiteren Autor:innen. Beteiligte Einrichtung: Istituto di Ricerche Chimiche e Biochimiche G. Ronzoni, via G. Colombo 81, 20133 Milano, Italy. Electronic address: niminghong@ronzoni.it. Hauptthemen laut MEDLINE: Glucuronidase, Heparin, Molecular Docking Simulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Heparanase is the only known endo-β-glucuronidase able to cleave heparan sulfate, participating in degradation and remodelling of the extracellular matrix. Heparanase upregulation promotes tumor growth and metastasis, therefore, its inhibition is a target for anticancer therapies. Heparan sulfate mimetics bearing glycol-split (gs) units are one of the most promising class of heparanase inhibitors. Herein we describe a total synthesis of two trisaccharides (MeO-GlcNS6S-IdoA/GlcA-GlcNS6S-OMe) differing in epimeric uronic acid residues and one tetrasaccharide (MeO-IdoA-GlcNS6S-IdoA-GlcNS6S-OMe), together with their corresponding glycol-split versions, prepared by periodate oxidation and further modified either via reduction or Pinnick oxidation to obtain gs or tricarboxylated saccharides. An intermediate imine was observed during periodate oxidation, which causes formation of byproducts. Evaluation of the heparanase inhibitory activity showed that the glycol-split trisaccharides were more potent than their intact uronic acid congeners. The binding interactions of the glycol-split trisaccharides with heparanase were investigated by a combined STD NMR and molecular docking approach, with good agreement obtained between the STD NMR experimental data, docking calculations and the in vitro activity results, helping to rationalize the observed inhibition data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Istituto di Ricerche Chimiche e Biochimiche G. Ronzoni, via G. Colombo 81, 20133 Milano, Italy. Electronic address: niminghong@ronzoni.it.
- Istituto di Ricerche Chimiche e Biochimiche G. Ronzoni, via G. Colombo 81, 20133 Milano, Italy.
- Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion, Haifa 3525422, Israel.
- The University of Queensland, Brisbane, QLD 4072, Australia.
- Centro Alta Tecnologia "Istituto di Ricerche Chimiche e Biochimiche G. Ronzoni" Srl, via G. Colombo 81, 20133 Milan, Italy.
Zitieren
APA
Ni, M., Parafioriti, M., Esposito, E., Danzi, M., Cano, O., Muzi, L., Kayal, Y., Ferro, V., Vlodavsky, I., Elli, S., Naggi, A., Petitou, M., & Guerrini, M. (2025). Synthetic glycol-split heparin tri- and tetrasaccharides provide new insights into structural peculiarities for antiheparanase activity. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2024.118052
Vancouver
Ni M, Parafioriti M, Esposito E, Danzi M, Cano O, Muzi L, et al. Synthetic glycol-split heparin tri- and tetrasaccharides provide new insights into structural peculiarities for antiheparanase activity. Bioorganic & Medicinal Chemistry. 2025. doi:10.1016/j.bmc.2024.118052
BibTeX
@article{Ni2025,
author = {Ni, Minghong and Parafioriti, Michela and Esposito, Emiliano and Danzi, Margherita and Cano, Ornela and Muzi, Laura and Kayal, Yasmin and Ferro, Vito and Vlodavsky, Israel and Elli, Stefano and Naggi, Annamaria and Petitou, Maurice and Guerrini, Marco},
title = {Synthetic glycol-split heparin tri- and tetrasaccharides provide new insights into structural peculiarities for antiheparanase activity},
journal = {Bioorganic & Medicinal Chemistry},
year = {2025},
doi = {10.1016/j.bmc.2024.118052}
}
EUVIMED